Lidocaine And Neuromonitoring in Thyroid Surgery
Intravenous Or Topical Lidocaine And Neuromonitoring in Thyroid Surgery (IOLANT Study)
Sponsor: Saint Petersburg State University, Russia
A PHASE4 clinical study on Anesthesia and Parathyroid Neoplasms, this trial is completed. The trial is conducted by Saint Petersburg State University, Russia and has accumulated 11 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Apr 2024 — Jul 2024 [monthly]
Completed PHASE4
Status: Suspended → Completed
-
Nov 2023 — Apr 2024 [monthly]
Suspended PHASE4
Status: Recruiting → Suspended
▶ Show 6 earlier versions
-
Sep 2022 — Nov 2023 [monthly]
Recruiting PHASE4
-
Mar 2021 — Sep 2022 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Feb 2021 — Mar 2021 [monthly]
Not Yet Recruiting PHASE4
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE4
-
Nov 2020 — Dec 2020 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Saint Petersburg State University, Russia
For direct contact, visit the study record on ClinicalTrials.gov .